Cytodyn Inc (CYDY)

[Leronlimab4DaWin]

Critical Placebo Mortality Rate of 29.9%

Relief Trial Data
See here

Remember this was only CRITICAL patients, while CYDY is a mix of critical and severe

Why are you even bothering pumping the stock?! In order for Leronlimab to have p-value < 0.05, and be approved, placebo mortality rate needs to be >31%. This trial just proved what KGRO and JUSTDA have been saying, it is impossible to get >31% given most recent trial results in critical and severe studies.

GAME OVER GOOD LUCK WITH THE HIV BLA (which is only worth about $50mm if you get it or $0.10 PPS)